Zoe Hughes

Company: Gilgamesh Pharmaceutical

Job title: Head of Medical Affairs

Seminars:

Using Translational Techniques to Advance Next Generation 5-HT2A Agonists into the Clinic to Treat Depression 3:30 pm

Developing an optimized small molecule agonist of 5-HT2A receptors Utilization of biomarkers with high-translational value to guide dose selection for evaluating the safety and efficacy of small molecules targeting the CNS Reviewing 5-HT2A receptor binding in vitro, in vivo and the markers of target engagement from the bench to Phase I clinical trialsRead more

day: Day Two AM